サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：抗体療法市場：タイプ別（モノクローナル抗体（がん、自己免疫疾患、感染症）、抗体薬物複合体）、エンドユーズ別の世界予測 2023-2032
市場調査レポート
商品コード
1416204

抗体療法市場：タイプ別（モノクローナル抗体（がん、自己免疫疾患、感染症）、抗体薬物複合体）、エンドユーズ別の世界予測 2023-2032

Antibody Therapy Market - By Type [Monoclonal Antibodies (mAbs) {Oncology, Autoimmune Disease, Infectious Disease}, Antibody-drug Conjugates (ADCs)], By End-use (Hospitals, Specialty Centers) - Global Forecast, 2023 - 2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 150 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
抗体療法市場：タイプ別（モノクローナル抗体（がん、自己免疫疾患、感染症）、抗体薬物複合体）、エンドユーズ別の世界予測 2023-2032
出版日: 2023年12月04日
発行: Global Market Insights Inc.
ページ情報: 英文 150 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

抗体療法市場規模は、2023年から2032年にかけてCAGR 11.8％で拡大すると予測されています。

がんや自己免疫疾患などの慢性疾患の増加により、標的を絞った個別化治療に対する需要が高まっています。

バイオテクノロジーと免疫学の進歩の増加は、新規でより効果的な抗体療法の開発を後押ししています。例えば、2023年9月、Manaolana Oncology Inc.がテキサス大学MDアンダーソンがんセンターとPanacea Ventureの協力により正式に発足し、新たながん抗原を標的とする抗体ベースの治療法の開発と進歩を図っています。また、副作用の軽減や治療成績の改善など、抗体療法の利点に対する認識が高まっていることも、需要を拡大させると思われます。抗体医薬の研究開発活動への投資の増加や、様々な医療分野での応用範囲の拡大は、市場の拡大をさらに促進するでしょう。

抗体医薬産業は、タイプ、最終用途、地域に分類されます。

抗体薬物複合体セグメントの市場シェアは、2023年から2032年にかけてCAGR 11.6%で上昇すると推定されます。これは主に、研究開発活動の増加、がんの有病率の上昇、バイオテクノロジーの急速な進歩によるものです。また、標的療法や個別化療法に対する需要の高さも、同分野の成長を後押しします。

専門施設の最終用途分野による抗体療法市場シェアは、2023年から2032年にかけてCAGR 12.5％で上昇すると予測されています。この成長は、慢性疾患の有病率の増加、専門的治療を求める患者層の拡大、精密医療の進歩の高まりに起因しています。さらに、専門施設は標的治療を提供する上で重要な役割を担っており、こうした施設での抗体療法の採用を後押ししています。

地域別では、欧州の抗体療法市場規模は2023年から2032年にかけて11.6%の成長率で拡大すると予測されており、これは慢性疾患の有病率の増加とバイオ医薬品の研究開発投資の増加によるものです。さらに、個別化医療に対する意識の高まりや良好な規制環境の存在が、同地域全体の抗体療法需要を後押しします。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 抗体療法業界洞察

  • エコシステム分析
  • 業界への影響要因
    • 促進要因
      • 世界の慢性疾患および感染症の流行増加
      • 研究開発活動の成長
      • 米国および欧州での高い採用率および承認率
      • 生物製剤産業の活況
      • 抗体療法の用途拡大
    • 業界の潜在的リスク＆課題
      • 一部のモノクローナル抗体治療薬の高コスト
      • 複雑な製造プロセスと物流の課題
  • 成長の可能性分析
  • COVID-19インパクト分析
  • パイプライン製品
    • モノクローナル抗体
    • 抗体薬物複合体
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業シェア分析
  • 主要市場プレーヤーの競合分析
  • 企業ポジショニングマトリックス
  • 戦略展望マトリックス

第5章 抗体療法の市場規模・予測：タイプ別、2018年～2032年

  • 主要動向：タイプ別
  • モノクローナル抗体（mAbs）
    • がん領域
    • 自己免疫疾患
    • 感染症
    • その他のモノクローナル抗体（mAbs）
  • 抗体薬物複合体（ADC）

第6章 抗体療法の市場規模・予測：最終用途別、2018年～2032年

  • 主要動向：エンドユーザー別
  • 病院
  • 専門施設
  • その他のエンドユーザー

第7章 抗体療法の市場規模・予測：地域別、2018-2032年

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • シンガポール
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • UAE
    • クウェート
    • エジプト
    • その他中東とアフリカ

第8章 企業プロファイル

  • F. Hoffmann-La Roche Ltd.
  • AbbVie, Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Seagen
  • Merck & Co., Inc.
  • Regeneron Pharmaceuticals Inc.
  • Novartis AG
  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline plc.
  • Takeda Pharmaceutical Company Ltd.
図表

Data Tables

  • TABLE 1 Market revenue, by type (2022)
  • TABLE 2 Market revenue, by end-use (2022)
  • TABLE 3 Market share, by region (2022)
  • TABLE 4 Global antibody therapy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 5 Global antibody therapy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 6 Global antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 7 Global antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 8 Global antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 9 Global antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 10 Industry impact forces
  • TABLE 11 Monoclonal antibodies (mAb) market size, 2018 - 2022 (USD Million)
  • TABLE 12 Monoclonal antibodies (mAb) market size, 2023 - 2032 (USD Million)
  • TABLE 13 Oncology market size, 2018 - 2022 (USD Million)
  • TABLE 14 Oncology market size, 2018 - 2022 (USD Million)
  • TABLE 15 Autoimmune diseases market size, 2023 - 2032 (USD Million)
  • TABLE 16 Autoimmune diseases market size, 2018 - 2022 (USD Million)
  • TABLE 17 Infectious diseases market size, 2018 - 2022 (USD Million)
  • TABLE 18 Infectious diseases market size, 2023 - 2032 (USD Million)
  • TABLE 19 Other monoclonal antibodies (mAbs) market size, 2023 - 2032 (USD Million)
  • TABLE 20 Other monoclonal antibodies (mAbs) market size, 2018 - 2022 (USD Million)
  • TABLE 21 Antibody-drug conjugates (ADCs) market size, 2023 - 2032 (USD Million)
  • TABLE 22 Antibody-drug conjugates (ADCs) market size, 2018 - 2022 (USD Million)
  • TABLE 23 North America antibody therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 24 North America antibody therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 25 North America antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 26 North America antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 27 North America antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 28 North America antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 29 North America antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 30 North America antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 31 U.S. antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 32 U.S. antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 33 U.S. antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 34 U.S. antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 35 U.S. antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 36 U.S. antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 37 Canada antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 38 Canada antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 39 Canada antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 40 Canada antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 41 Canada antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 42 Canada antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 43 Europe antibody therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 44 Europe antibody therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 45 Europe antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 46 Europe antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 47 Europe antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 48 Europe antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 49 Europe antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 50 Europe antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 51 Germany antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 52 Germany antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 53 Germany antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 54 Germany antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 55 Germany antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 56 Germany antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 57 UK antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 58 UK antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 59 UK antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 60 UK antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 61 UK antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 62 UK antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 63 France antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 64 France antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 65 France antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 66 France antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 67 France antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 68 France antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 69 Spain antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 70 Spain antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 71 Spain antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 72 Spain antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 73 Spain antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 74 Spain antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 75 Italy antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 76 Italy antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 77 Italy antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 78 Italy antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 79 Italy antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 80 Italy antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 81 Rest of Europe antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 82 Rest of Europe antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 83 Rest of Europe antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 84 Rest of Europe antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 85 Rest of Europe antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 86 Rest of Europe antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 87 Asia Pacific antibody therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 88 Asia Pacific antibody therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 89 Asia Pacific antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 90 Asia Pacific antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 91 Asia Pacific antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 92 Asia Pacific antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 93 Asia Pacific antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 94 Asia Pacific antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 95 China antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 96 China antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 97 China antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 98 China antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 99 China antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 100 China antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 101 Japan antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 102 Japan antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 103 Japan antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 104 Japan antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 105 Japan antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 106 Japan antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 107 India antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 108 India antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 109 India antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 110 India antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 111 India antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 112 India antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 113 Australia antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 114 Australia antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 115 Australia antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 116 Australia antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 117 Australia antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 118 Australia antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 119 Singapore antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 120 Singapore antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 121 Singapore antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 122 Singapore antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 123 Singapore antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 124 Singapore antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 125 Rest of Asia Pacific antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 126 Rest of Asia Pacific antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 127 Rest of Asia Pacific antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 128 Rest of Asia Pacific antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 129 Rest of Asia Pacific antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 130 Rest of Asia Pacific antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 131 Latin America antibody therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 132 Latin America antibody therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 133 Latin America antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 134 Latin America antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 135 Latin America antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 136 Latin America antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 137 Latin America antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 138 Latin America antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 139 Brazil antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 140 Brazil antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 141 Brazil antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 142 Brazil antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 143 Brazil antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 144 Brazil antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 145 Mexico antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 146 Mexico antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 147 Mexico antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 148 Mexico antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 149 Mexico antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 150 Mexico antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 151 Argentina antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 152 Argentina antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 153 Argentina antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 154 Argentina antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 155 Argentina antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 156 Argentina antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 157 Rest of Latin America antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 158 Rest of Latin America antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 159 Rest of Latin America antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 160 Rest of Latin America antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 161 Rest of Latin America antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 162 Rest of Latin America antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 163 Middle East & Africa antibody therapy market size, By country, 2018 - 2022 (USD Million)
  • TABLE 164 Middle East & Africa antibody therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 165 Middle East & Africa antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 166 Middle East & Africa antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 167 Middle East & Africa antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 168 Middle East & Africa antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 169 Middle East & Africa antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 170 Middle East & Africa antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 171 South Africa antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 172 South Africa antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 173 South Africa antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 174 South Africa antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 175 South Africa antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 176 South Africa antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 177 Saudi Arabia antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 178 Saudi Arabia antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 179 Saudi Arabia antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 180 Saudi Arabia antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 181 Saudi Arabia antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 182 Saudi Arabia antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 183 UAE antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 184 UAE antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 185 UAE antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 186 UAE antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 187 UAE antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 188 UAE antibody therapy market size, by end-use, 2023 - 2032 (USD Million) Saudi Arabia antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 189 Kuwait antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 190 Kuwait antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 191 Kuwait antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 192 Kuwait antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 193 Kuwait antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 194 Egypt antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 195 Egypt antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 196 Egypt antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 197 Egypt antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 198 Egypt antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 199 Egypt antibody therapy market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 200 Rest of Middle East & Africa antibody therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 201 Rest of Middle East & Africa antibody therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 202 Rest of Middle East & Africa antibody therapy market size, by monoclonal antibodies (mAb), 2018 - 2022 (USD Million)
  • TABLE 203 Rest of Middle East & Africa antibody therapy market size, by monoclonal antibodies (mAb), 2023 - 2032 (USD Million)
  • TABLE 204 Rest of Middle East & Africa antibody therapy market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 205 Rest of Middle East & Africa antibody therapy market size, by end-use, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Antibody therapy industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by type
  • FIG 8 Growth potential analysis, by end-use
  • FIG 9 Porter's analysis
  • FIG 10 PESTEL analysis
  • FIG 11 Company matrix analysis, 2022
  • FIG 12 Competitive analysis of major market players, 2022
  • FIG 13 Competitive positioning matrix, 2022
  • FIG 14 Strategic dashboard, 2022
目次
Product Code: 5195

Antibody therapy market size is projected to expand at 11.8% CAGR from 2023 to 2032. The increasing prevalence of chronic diseases, such as cancer and autoimmune disorders, is fueling the demand for several targeted and personalized treatments.

The increasing advancements in biotechnology and immunology are encouraging the development of novel and more effective antibody therapies. For instance, in September 2023, Manaolana Oncology Inc. was officially launched through a collaboration between The University of Texas MD Anderson Cancer Center and Panacea Venture to develop and advance in antibody-based therapies for targeting the emerging cancer antigens. Additionally, the growing awareness of the benefits of antibody therapy, including reduced side effects and improved treatment outcomes will escalate their demand. The rising investments in R&D activities for antibody-based drugs and the expanding application scope in various medical fields will further drive the market expansion.

The antibody therapy industry is segregated into type, end-use, and region.

The market share from the antibody-drug conjugates segment is estimated to rise at 11.6% CAGR from 2023 to 2032. This is mainly on account of the increasing research and development activities, the rising prevalence of cancer, and the surging advancements in biotechnology. High demand for targeted and personalized therapies will also drive the segment growth.

Antibody therapy market share from the specialty centers end-use segment is projected to rise at 12.5% CAGR between 2023 and 2032. The growth can be attributed to the growing prevalence of chronic diseases, expanding patient pool seeking specialized care, and the rising advancements in precision medicine. Moreover, specialty centers play a crucial role in delivering targeted treatments, driving the adoption of antibody therapies in these centers.

Regionally, the Europe antibody therapy market size is projected to expand at 11.6% growth rate from 2023 and 2032, due to the increasing prevalence of chronic diseases and the rising biopharmaceutical R&D investments. Furthermore, the growing awareness about personalized medicine, and the presence of favorable regulatory environment will fuel the demand for antibody therapies across the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & workings
    • 1.2.1 Data collection
  • 1.3 Forecast calculations
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Antibody therapy market 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Type trends
    • 2.1.4 End-use trends

Chapter 3 Antibody Therapy Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic and infectious disease worldwide
      • 3.2.1.2 Growing R&D activities
      • 3.2.1.3 High rate of adoption and approval in the U.S. and Europe
      • 3.2.1.4 Booming biologics industry
      • 3.2.1.5 Rising applications of antibody therapy
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of some monoclonal antibody therapeutics
      • 3.2.2.2 Complex manufacturing processes and logistical challenges
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By end-use
  • 3.4 COVID- 19 impact analysis
  • 3.5 Pipeline products
    • 3.5.1 Monoclonal antibodies
    • 3.5.2 Antibody drug conjugates
  • 3.6 Regulatory landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company market share analysis, 2022
  • 4.3 Competitive analysis of major market players, 2022
  • 4.4 Company positioning matrix, 2022
  • 4.5 Strategy outlook matrix, 2022

Chapter 5 Antibody Therapy Market Size and Forecast, By Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by type
  • 5.2 Monoclonal antibodies (mAbs)
    • 5.2.1 Oncology
    • 5.2.2 Autoimmune diseases
    • 5.2.3 Infectious diseases
    • 5.2.4 Other monoclonal antibodies (mAbs)
  • 5.3 Antibody-drug conjugates (ADCs)

Chapter 6 Antibody Therapy Market Size and Forecast, By End-use, 2018-2032 (USD Million)

  • 6.1 Key trends, by end-use
  • 6.2 Hospitals
  • 6.3 Specialty centers
  • 6.4 Other end-users

Chapter 7 Antibody Therapy Market Size and Forecast, By Region, 2018-2032 (USD Million)

  • 7.1 Key trends, by region
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 Singapore
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East & Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Kuwait
    • 7.6.5 Egypt
    • 7.6.6 Rest of Middle East & Africa

Chapter 8 Company Profiles

  • 8.1 F. Hoffmann-La Roche Ltd.
  • 8.2 AbbVie, Inc.
  • 8.3 Amgen Inc.
  • 8.4 Bristol-Myers Squibb Company
  • 8.5 Johnson & Johnson Services, Inc.
  • 8.6 Seagen
  • 8.7 Merck & Co., Inc.
  • 8.8 Regeneron Pharmaceuticals Inc.
  • 8.9 Novartis AG
  • 8.10 AstraZeneca
  • 8.11 Eli Lilly and Company
  • 8.12 GlaxoSmithKline plc.
  • 8.13 Takeda Pharmaceutical Company Ltd.